79.07

1.17% -0.94

Pre-market: 76.70 -2.37 -3.00%

Sol Gel Technologies Ltd (SLGL)

Overview News Price History Option Chain Discussions Forecast

Sol Gel Technologies Ltd stock is traded at $79.07, with a volume of 67,711. It is down -1.17% in the last 24 hours and down -12.26% over the past month. Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

Previous Close:

$80.01

Open:

$83.8

24h Volume:

67,711

Relative Volume:

2.48

Market Cap:

$222.18M

Revenue:

$18.97M

Net Income/Loss:

$-8.99M

P/E Ratio:

-24.51

EPS:

-3.2257

Net Cash Flow:

$-33.87M

1W Performance:

+4.95%

1M Performance:

-12.26%

6M Performance:

+182.49%

1Y Performance:

+1,314%

1-Day Range:

$75.00

$83.80

1-Week Range:

$61.92

$93.53

52-Week Range:

$4.018

$97.97

Sol Gel Technologies Ltd Stock (SLGL) Company Profile

Name

Sol Gel Technologies Ltd

Sector

Healthcare (1114)

Industry

Biotechnology (623)

Phone

Address

Employee

Twitter

Next Earnings Date

2025-08-15

Latest SEC Filings

SLGL's Discussions on Twitter

Compare SLGL vs VRTX, REGN, ALNY, ARGX, INSM

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SLGL Sol Gel Technologies Ltd	79.07	222.18M	18.97M	-8.99M	-33.87M	-3.2257
VRTX Vertex Pharmaceuticals Inc	454.97	115.58B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	749.47	79.23B	14.34B	4.50B	3.77B	41.56
ALNY Alnylam Pharmaceuticals Inc	328.70	43.59B	3.71B	313.75M	465.38M	2.2571
ARGX Argen X Se Adr	697.05	43.26B	4.16B	1.29B	734.26M	19.58
INSM Insmed Inc	148.31	31.97B	606.42M	-1.28B	-997.58M	-6.403

Sol Gel Technologies Ltd Stock (SLGL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-19-24	Downgrade	Raymond James	Strong Buy → Outperform
Oct-21-22	Resumed	Jefferies	Hold
Dec-31-19	Reiterated	H.C. Wainwright	Buy
Dec-31-19	Reiterated	JMP Securities	Mkt Outperform

Sol Gel Technologies Ltd Stock (SLGL) Latest News

Mar 24, 2026

Sol-Gel Technologies Prices $33.1 Million Oversubscribed Equity Offering to Advance SGT-610 - TipRanks

Mar 24, 2026

Sol-Gel (NASDAQ: SLGL) prices $33.1M oversubscribed share offering - Stock Titan

Mar 24, 2026

Sol‑Gel (NASDAQ: SLGL) raises ~$30.8M via 459,112‑share offering to fund SGT‑610 - Stock Titan

Mar 24, 2026

Opaleye Management (SLGL) linked entities buy 39,665 Sol-Gel shares - Stock Titan

Mar 24, 2026

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Mar 24, 2026

Sol-Gel Technologies (SLGL) Prices Oversubscribed Offering, Shar - GuruFocus

Mar 24, 2026

SLGL Announces Offering with TD Cowen and LifeSci Capital as Managers - GuruFocus

Mar 24, 2026

[EFFECT] Sol-Gel Technologies... | SLGL SEC FilingForm EFFECT - Stock Titan

Mar 24, 2026

Mar 23, 2026

Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering - weeklyvoice.com

Mar 23, 2026

Sol-Gel brings in $33.1M to fund SGT-610 development - Stock Titan

Mar 23, 2026

Sol-Gel Technologies Ltd. announces pricing of oversubscribed underwritten offering - marketscreener.com

Mar 23, 2026

Sol-Gel Technologies Ltd. Announces Pricing of $33.1 Million Underwritten Offering of Ordinary Shares - Quiver Quantitative

Mar 23, 2026

Sol-Gel Technologies Ltd. Announces Pricing Of Oversubscribed Underwritten Offering - TradingView

Mar 23, 2026

Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering - GlobeNewswire Inc.

Mar 23, 2026

Opaleye (SLGL) affiliate discloses 460,335 shares, 16.52% stake - Stock Titan

Mar 23, 2026

Mar 22, 2026